Deep Learning in Therapeutic Antibody Development
- 4 November 2021
- book chapter
- Published by Springer Nature
- Vol. 2390, 433-445
Abstract
Deep learning applied to antibody development is in its adolescence. Low data volumes and biological platform differences make it challenging to develop supervised models that can predict antibody behavior in actual commercial development steps. But successes in modeling general protein behaviors and early antibody models give indications of what is possible for antibodies in general, particularly since antibodies share a common fold. Meanwhile, new methods of data collection and the development of unsupervised and self-supervised deep learning methods like generative models and masked language models give the promise of rich and deep data sets and deep learning architectures for better supervised model development. Together, these move the industry toward improved developability, lower costs, and broader access of biotherapeutics.Keywords
This publication has 28 references indexed in Scilit:
- Modeling of complex antibody elution behavior under high protein load densities in ion exchange chromatography using an asymmetric activity coefficientBiotechnology Journal, 2017
- Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain AntibodiesPLOS ONE, 2016
- Advances in recombinant antibody manufacturingApplied Microbiology and Biotechnology, 2016
- Development of a quantitative mass spectrometry multi-attribute method for characterization, quality control testing and disposition of biologicsmAbs, 2015
- Generating thermal stable variants of protein domains through phage displayMethods, 2013
- PROSO II – a new method for protein solubility predictionThe FEBS Journal, 2012
- Probing protein stability and proteolytic resistance by loop scanning: A comprehensive mutational analysisProtein Science, 2012
- Glycan Engineering and Production of 'Humanized' Glycoprotein in Yeast CellsBiological and Pharmaceutical Bulletin, 2009
- High‐Throughput Process Development: Determination of Dynamic Binding Capacity Using Microtiter Filter Plates Filled with Chromatography ResinBiotechnology Progress, 2008
- Yet Another Numbering Scheme for Immunoglobulin Variable Domains: An Automatic Modeling and Analysis ToolJournal of Molecular Biology, 2001